Interestingly, recent studies have demonstrated that LDHA is inhibited in the isocitrate dehydrogenase (IDH) subgroup of glioma, which has characteristically slow progression, greater survival rates and better prognosis than the other glioblastoma multiforme (GBM) subgroups 14. Here, IDH3A is linked to glioblastoma.